JNJannie Toft Damsgaard Nørlev

Jannie Toft Damsgaard Nørlev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jannie Toft Damsgaard Nørlev has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Stine Hangaard

    Department of Health Science and Technology, Aalborg University, Denmark

    8 shared publications
  • Thomas Kronborg

    Department of Health Science and Technology, Aalborg University, Denmark

    5 shared publications
  • Ole Hejlesen

    Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Gistrup, Denmark

    4 shared publications
  • Peter Vestergaard

    Steno Diabetes Center North Denmark, Hospitalsbyen 4, Aalborg DK-9000, Denmark; Dept. of Clinical Medicine, Aalborg University, Selma Lagerløfs Vej 249, DK-9260, Aalborg, Gistrup DK-9000, Denmark; Dept. of Endocrinology, Aalborg University Hospital, Mølleparkvej 4, Aalborg DK-9000, Denmark

    4 shared publications
  • Morten Hasselstrøm Jensen

    Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Gistrup, Denmark

    3 shared publications
  • Morten Hasselstrøm Jensen

    Department of Health Science and Technology Aalborg University Aalborg Denmark

    3 shared publications

Latest Publications

  • Open Access

    Insulin pens and the digital ecosystem

    by Johan Jendle, Peter Adolfsson, Roque Cardona-Hernandez, Laurent Crenier, Sergio Di Molfetta, Dominic Ehrmann, Francesco Giorgino, Martin Haluzik, Irl B. Hirsch, Concetta Irace, et al.

    Insulin has been used for over a century for the treatment of diabetes and, since the mid-1980s, there has been a rapid development of insulin administration tools. Over the last decade, several medical products used for diabetes management have been connected to a digital ecosystem. This connectivity includes sophisticated monitoring of not only glucose levels but also of insulin delivery (type, dose, time of dosing). It facilitates interactions between people with diabetes, various diabetes technology devices and healthcare professionals. This white paper aims to discuss and categorise different types of insulin pens, connected insulin pens and caps, as well as smart insulin pen systems (SPSs) that are available on the market. Connected pens capture data to provide information about the details of the insulin applied. SPSs are paired with a continuous glucose monitoring (CGM) system and, by means of integrated algorithms, can provide individualised dose calculation based on a variety of factors. These SPSs can also recommend insulin doses based on current and projected glucose and insulin data; this feature requires a connection to a CGM system. Yet what are the clinical advantages of SPSs? What added value does this system bring to individuals living with diabetes and their healthcare providers? In a narrative review, we discuss the current regulatory pathways and market environment as well as the influencing factors of connected insulin pens vs SPSs. We aim to provide a rationale and justification for this categorisation based on (smart) design aspects, regulatory considerations and clinical outcomes. This review concludes that while standard insulin pens remain a safe and commonly offered option, connected insulin pens and SPSs are likely to show improvement in glycaemic management, treatment adherence and patient satisfaction, and represent a significant advancement in diabetes care. However, further research including high-quality clinical and health economic studies will be vital in substantiating the value of both connected insulin pens and SPSs and driving broader acceptance among payers and healthcare systems. Graphical Abstract

  • Open Access

    Development of a Digitally Applicable Tool for Identifying Insulin Adherence Challenges Prior to Consultation

    by Jannie Nørlev, Stine Hangaard

    Adherence to insulin therapy is crucial for optimal glycemic control in people with diabetes. Yet, non-adherence is common, and identifying those struggling with adherence remains challenging. This study developed and validated a questionnaire designed to assess insulin adherence among people with insulin-treated diabetes. A 10-item questionnaire in Danish was developed based on a literature review, prior research on insulin use patterns, and expert evaluation. Content validity was evaluated by a panel of five domain experts who independently rated item relevance on a 4-point scale. Item-level Content Validity Index (I-CVI), Scale-level CVI (S-CVI/Ave), and modified kappa (κ*) were computed. All ten items were rated as relevant (scores 3–4) by all experts, resulting in I-CVI = 1.00 and κ* = 1.00 for all items. The overall scale (S-CVI/Ave) demonstrated excellent content validity. The insulin adherence questionnaire appears to comprehensively capture different aspects of insulin-taking behavior. The questionnaire holds promise for both clinical and educational use, particularly when administered digitally prior to consultations. This allows healthcare professionals to identify adherence challenges and tailor patient education and support.

  • Open Access

    Understanding insulin dose deviations in people with type 2 diabetes receiving telemonitoring

    by Jannie Toft Damsgaard Nørlev, Thomas Kronborg, Morten Hasselstrøm Jensen, Peter Vestergaard, Stine Hangaard


  • Open Access

    Assessment of basal insulin adherence in people with type 2 diabetes in telemonitoring: Post-hoc analysis of novel data modalities including insulin injection data

    by Jannie Toft Damsgaard Nørlev, Thomas Kronborg, Morten Hasselstrøm Jensen, Priyanka Rana, Peter Vestergaard, Stine Hangaard


  • Identifying the Relationship Between Continuous Glucose Monitor Time in Range and Basal Insulin Adherence in People With Type 2 Diabetes

    by Jannie Toft Damsgaard Nørlev, Thomas Kronborg, Morten Hasselstrøm Jensen, Peter Vestergaard, Ole Hejlesen, Stine Hangaard

    Background: The study aimed to determine the relationship between basal insulin adherence and glycemic control evaluated by time in range (TIR) in people with insulin-treated type 2 diabetes (T2D), using data from both continuous glucose monitors (CGM) and connected insulin pens. Furthermore, the study aimed to determine the best basal insulin adherence metric. Methods: CGM data and basal insulin data were collected from 106 insulin-treated people (aged ≥18 years) with T2D. Three different adherence metrics were employed (dose deviation, dose deviation ≤20%, and a traditional metric) and a three-step methodology was used to measure insulin adherence level. The coefficient of determination (R 2 ), based on a univariate linear regression analysis, was used to determine the relationship between each adherence metric and TIR. Results: A statistically significant relationship was observed between TIR and adherence quantified as the dose deviation ≤20% metric (R 2 = 0.67, P = .006). Neither the relationship between the dose deviation metric and TIR (R 2 = 0.43, P = .08) nor the relationship between the traditional metric and TIR (R 2 = 0.35, P =.23) was found to be statistically significant. Conclusions: Our study indicates a relationship between basal insulin adherence and TIR in people with insulin-treated T2D. This seems to underscore the role of basal insulin adherence for optimal glycemic outcomes and utilizing TIR as a clinical marker. Furthermore, the results suggest that the magnitude of deviation from the recommended basal insulin dose impacts glycemic control, indicating dose deviation ≤20% as a more accurate metric for quantifying adherence.


  • Open Access

    Detailed Insights into Basal Insulin Adherence in People with Type 2 Diabetes Using a Data-Driven Assessment Method

    by Jannie Nørlev, Thomas Kronborg, Ole Hejlesen, Morten Hasselstrøm, Peter Vestergaard, Stine Hangaard

    Introduction: Basal insulin non-adherence is a challenge in people with type 2 diabetes (T2D). Methods: Using injection data recorded by a connected insulin pen, we employed a novel three-step methodology to assess three aspects of adherence (overall adherence, adherence distribution, and dose deviation) in individuals with insulin-treated T2D undergoing telemonitoring. Results: Among participants, 52% were considered overall adherent. However, deviations from the recommended dose were observed in all participants, with increased and reduced doses being the predominant forms of non-adherence. Conclusions: Our study underscores the prevalence of basal insulin dosing irregularities in individuals with insulin-treated T2D undergoing telemonitoring.

  • A Three-Step Data-Driven Methodology to Assess Adherence to Basal Insulin Therapy in Patients With Insulin-Treated Type 2 Diabetes

    by Jannie Toft Damsgaard Nørlev, Thomas Kronborg, Morten Hasselstrøm Jensen, Peter Vestergaard, Ole Hejlesen, Stine Hangaard

    Background: While health care providers (HCPs) are generally aware of the challenges concerning insulin adherence in adults with insulin-treated type 2 diabetes (T2D), data guiding identification of insulin nonadherence and understanding of injection patterns have been limited. Hence, the aim of this study was to examine detailed injection data and provide methods for assessing different aspects of basal insulin adherence. Method: Basal insulin data recorded by a connected insulin pen and prescribed doses were collected from 103 insulin-treated patients (aged ≥18 years) with T2D from an ongoing clinical trial (NCT04981808). We categorized the data and analyzed distributions of correct doses, increased doses, reduced doses, and missed doses to quantify adherence. We developed a three-step model evaluating three aspects of adherence (overall adherence, adherence distribution, and dose deviation) offering HCPs a comprehensive assessment approach. Results: We used data from a connected insulin pen to exemplify the use of the three-step model to evaluate overall, adherence, adherence distribution, and dose deviation using patient cases. Conclusion: The methodology provides HCPs with detailed access to previously limited clinical data on insulin administration, making it possible to identify specific nonadherence behavior which will guide patient-HCP discussions and potentially provide valuable insights for tailoring the most appropriate forms of support.


  • Open Access

    Quantification of insulin adherence in adults with insulin-treated type 2 diabetes: A systematic review

    by Jannie Toft Damsgaard Nørlev, Ole Hejlesen, Morten Hasselstrøm Jensen, Stine Hangaard


  • Open Access

    Using Distance Communication for the User-Centered Development of a Smartphone-Based Serious Game for Children With Type 1 Diabetes: Participatory Design Approach

    by Jannie Nørlev, Christina Derosche, Katrine Sondrup, Ole Hejlesen, Stine Hangaard

    Background: The complications of type 1 diabetes (T1D) can be delayed or prevented in children with T1D who receive proper self-management education. Smartphone-based serious games are increasingly being used as an effective tool for teaching self-management. When developing a serious game, it is important that the development process be user-centered. Traditionally, different face-to-face methods have been used when children participate in the development process. However, face-to-face data collection is not always feasible. In such situations, distance communication can be used when developing a serious game. Objective: The objective of this study is to develop a user-centered smartphone-based serious game that teaches self-management focused on carbohydrate intake in children aged 8-14 years with T1D using distance communication in both the development and evaluation of the game. Methods: The development and evaluation of a smartphone-based serious game prototype was inspired by the Lean principles, and a user-centered approach was applied. The development process included 1 expert interview and design workshops with children with T1D. On the basis of the interview and design workshop results, a serious game prototype was developed using Microsoft PowerPoint. The evaluation of the serious game prototype included an interview with a dietitian and a playtest with children with T1D. All data were collected using distance communication. Results: A user-centered smartphone-based serious game prototype was developed and evaluated. The expert interview with the dietitian formed the basis for the learning outcomes in the game. Four children and their parents contributed to the preferences, needs, requirements, and ideas for selected parts of the game design. The dietitian evaluated the prototype positively and validated its content and accuracy. The serious game prototype was well-received by the children and their parents during the playtest. The serious game prototype was perceived as a useful and engaging way to learn. However, the difficulty level was not appropriate, and the information was too basic for participants who had been diagnosed over a year ago. The use of digital communication platforms did not cause any problems. Conclusions: The smartphone-based serious game prototype has the potential to be a useful and attractive tool for teaching disease self-management. The use of distance communication proved to be a useful approach in the development of a serious game.